This trial has completed recruitment on this platform, and is no longer accepting new referrals.
A retreatment study with brentuximab vedotin in subjects with classical Hodgkin lymphoma or peripheral T cell lymphoma whose cancer got better after taking brentuximab vedotin, and subsequently got worse. USM/BVM/2021/0037
Trial ID: NCT03947255
Please visit https://clinicaltrials.gov/study/NCT03947255 for more information.
This study is no longer recruiting participants. Please visit https://clinicaltrials.gov/study/NCT03947255 for more information.
This study is no longer recruiting participants. Please visit https://clinicaltrials.gov/study/NCT03947255 for more information.
Please visit https://clinicaltrials.gov/study/NCT03947255 for more information.